To test our hypothesis, IHC staining of CD8, CD25, granulysin, and Foxp3 was performed for 21 cases of CTCL treated with bexarotene (Table 1). This evidence concerns the gene CD8A and primary cutaneous T-cell non-Hodgkin lymphoma.